Scarlett Chen from Verge HealthTech Fund joins ViewMind’s board of directors
ViewMind today announced Scarlett Sijia Chen, Managing Partner of Verge HealthTech Fund, has been elected to ViewMind’s board of directors. Scarlett brings decades of experience in health tech investing, buy-side, and investment banking
Related Posts
Our paper has been published in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. Mario A Parra MD PhD, Juan Granada MD, gerardo fernandez PhD, et al. (2022). In a 40-month prospective study, ViewMind showed:
Highlights: • A biomarker to ‘prospectively’ predict Alzheimer’s Disease with high accuracy. PPV 94% and NPV 100% • Ability to very accurately differentiate cognitive decline…
Memory-driven eye movements prospectively predict dementia in people at risk of Alzheimer’s disease
Oculomotor behaviors linked to cognitive performance revealed neurocognitive features of Alzheimer’s disease (AD) that can enhance the accuracy of its assessment and diagnosis
ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders
ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders Homepage >> Press Releases >> ViewMind announces developer agreement with HP to
